John Tsai's Insider Trades & SAST Disclosures

John Tsai's most recent trade in Blueprint Medicines Corp was a trade of 4,570 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Blueprint Medicines Corp
John Tsai Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 4,570 4,570 - - Stock Option (Right to Buy)
Blueprint Medicines Corp
John Tsai Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 2,242 8,742 (0%) 0% 0 Common Stock
Blueprint Medicines Corp
John Tsai Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 5,300 5,300 - - Stock Option (Right to Buy)
Blueprint Medicines Corp
John Tsai Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 2,600 6,500 (0%) 0% 0 Common Stock
Blueprint Medicines Corp
John Tsai Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 7,950 7,950 - - Stock Option (Right to Buy)
Blueprint Medicines Corp
John Tsai Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 3,900 3,900 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades